Anthony DeStefano presented on technological strategies for combating counterfeit medicines. He argued that standardized identification tools and spectral libraries are needed as most APIs and drug products are made outside the US. Industry requires sophisticated tools while governments can help drive standardization and broad detection. The USP could help provide standardized reference materials and spectral libraries to facilitate global identification efforts against counterfeits. Coordination between industry, governments, and organizations like USP is essential to addressing this global problem.